Development of siRNA Delivery Strategy by Active Control of Tumor Microenvironment
-
- Ishida Tatsuhiro
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, The University of Tokushima
-
- Kiwada Hiroshi
- Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, The University of Tokushima
Bibliographic Information
- Other Title
-
- 腫瘍内微小環境の能動的制御に基づくsiRNAデリバリー技術の開発とがん治療への展開
- シュヨウ ナイ ビショウ カンキョウ ノ ノウドウテキ セイギョ ニ モトズク siRNA デリバリー ギジュツ ノ カイハツ ト ガン チリョウ エ ノ テンカイ
Search this article
Description
Efficient systemic siRNA delivery to cells in the target tissue is a current critical challenge in the drug delivery field. Several studies have demonstrated that nanoparticles such as polyethylene glycol (PEG)-coated siRNA-lipoplexes may enhance the systemic delivery of siRNA to tumor. However, the disordered tumor microenvironment still poses a potential impediment with respect to the efficient delivery of PEG-coated siRNA-lipoplexes. We recently showed that metronomic S-1 dosing (daily oral administration) enhanced the accumulation of PEG-coated liposome containing anticancer drug in solid tumor tissue and thereby increased therapeutic efficacy in tumor-bearing mouse model. To extend this work, we tried to investigate the effect of metronomic S-1 dosing on the intratumoral accumulation of PEG-coated siRNA-lipoplex and, thereby, their therapeutic efficacy in solid tumor-bearing mouse model. Results showed that metronomic S-1 dosing improved systemic delivery of intravenously injected PEG-coated siRNA-lipoplexes into solid tumor tissue. In addition, the combined therapy of S-1 and PEG-coated siRNA-lipoplexes showed potent tumor growth suppressive effect. Our proposed strategy may pose a promising therapeutic one to conquer cancer progression with siRNA.<br>
Journal
-
- YAKUGAKU ZASSHI
-
YAKUGAKU ZASSHI 133 (3), 379-386, 2013-03-01
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390001206129003136
-
- NII Article ID
- 130003361927
-
- NII Book ID
- AN00284903
-
- COI
- 1:STN:280:DC%2BC3svit1yksQ%3D%3D
-
- ISSN
- 13475231
- 00316903
-
- NDL BIB ID
- 024312005
-
- PubMed
- 23449418
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- Abstract License Flag
- Disallowed